Volonté M, Ceci A, Borsini F
Department of CNS Pharmacology, Boehringer Ingelheim Italia, Milano.
Eur J Pharmacol. 1992 Mar 17;213(1):163-4. doi: 10.1016/0014-2999(92)90250-8.
(+)SKF 10,047 preferentially increased dopamine release in the nucleus accumbens compared to the striatum. Dopamine output was evaluated in the same freely moving rats by trans-cerebral dialysis. Clozapine and DAU 6215, a 5HT3 antagonist, which itself did not modify dopamine release in both areas, selectively antagonized (+)SKF 10,047-induced dopamine release in the nucleus accumbens. Haloperidol by itself increased dopamine release in both areas and these effects were additive with those induced by (+)SKF 10,047.
与纹状体相比,(+)SKF 10,047优先增加伏隔核中的多巴胺释放。通过经脑透析在相同的自由活动大鼠中评估多巴胺输出。氯氮平和5HT3拮抗剂DAU 6215本身不会改变这两个区域的多巴胺释放,但能选择性拮抗(+)SKF 10,047诱导的伏隔核多巴胺释放。氟哌啶醇本身会增加这两个区域的多巴胺释放,且这些作用与(+)SKF 10,047诱导的作用相加。